Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Net Cash Flow (2017 - 2026)

Sensus Healthcare has reported Net Cash Flow over the past 9 years, most recently at -$2.4 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 372.11% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached $27000.0, up 102.43%, while the annual FY2025 figure was $27000.0, 102.47% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$2.4 million at Sensus Healthcare, down from $2.3 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $18.3 million in Q1 2022 and troughed at -$12.1 million in Q4 2022.
  • A 5-year average of $357950.0 and a median of $793000.0 in 2022 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 1559.04% in 2022 and fell as far as 544.07% in 2022.
  • Year by year, Net Cash Flow stood at -$1.9 million in 2021, then crashed by 544.07% to -$12.1 million in 2022, then skyrocketed by 122.07% to $2.7 million in 2023, then tumbled by 118.87% to -$502000.0 in 2024, then crashed by 372.11% to -$2.4 million in 2025.
  • Business Quant data shows Net Cash Flow for SRTS at -$2.4 million in Q4 2025, $2.3 million in Q3 2025, and $3.1 million in Q2 2025.